李振华1，张建刚1，谢卫征1，王禹2，罗雪1，刘聪慧1，孙科1，杨清成1，郭艳平. (2023). 双联抗血小板对比阿替普酶治疗急性轻型非致残性缺血性卒中的有效性和安全性研究 Efficacy and Safety Study of Dual Antiplatelet Versus Alteplase in the Treatment of Acute Mild Non-Disabling Ischemic Stroke. Zhongguo cuzhong zazhi, 18(12), 1391-1396. https://doi.org/10.3969/j.issn.1673-5765.2023.12.008
Chicago Style (17th ed.) Citation李振华1，张建刚1，谢卫征1，王禹2，罗雪1，刘聪慧1，孙科1，杨清成1，郭艳平. "双联抗血小板对比阿替普酶治疗急性轻型非致残性缺血性卒中的有效性和安全性研究 Efficacy and Safety Study of Dual Antiplatelet Versus Alteplase in the Treatment of Acute Mild Non-Disabling Ischemic Stroke." Zhongguo Cuzhong Zazhi 18, no. 12 (2023): 1391-1396. https://doi.org/10.3969/j.issn.1673-5765.2023.12.008.
MLA (9th ed.) Citation李振华1，张建刚1，谢卫征1，王禹2，罗雪1，刘聪慧1，孙科1，杨清成1，郭艳平. "双联抗血小板对比阿替普酶治疗急性轻型非致残性缺血性卒中的有效性和安全性研究 Efficacy and Safety Study of Dual Antiplatelet Versus Alteplase in the Treatment of Acute Mild Non-Disabling Ischemic Stroke." Zhongguo Cuzhong Zazhi, vol. 18, no. 12, 2023, pp. 1391-1396, https://doi.org/10.3969/j.issn.1673-5765.2023.12.008.
